Related Experiment Video
Updated: Sep 20, 2025

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Robustness of the Autophagy Pathway to Somatic Copy Number Losses
Pierfrancesco Polo1, Niklas Gremke1,2, Thorsten Stiewe1,3,4
1Institute of Molecular Oncology, Philipps-University, 35043 Marburg, Germany.
Abstract:
Autophagy allows cells to temporarily tolerate energy stress by replenishing critical metabolites through self-digestion, thereby attenuating the cytotoxic effects of anticancer drugs that target tumor metabolism. Autophagy defects could therefore mark a metabolically vulnerable cancer state and open a therapeutic window. While mutations of autophagy genes (ATGs) are notably rare in cancer, haploinsufficiency network analyses across many cancers have shown that the autophagy pathway is frequently hit by somatic copy number losses of ATGs such as MAP1LC3B/ATG8F (LC3), BECN1/ATG6 (Beclin-1), and ATG10. Here, we used CRISPR/Cas9 technology to delete increasing numbers of copies of one or more of these ATGs in non-small cell lung cancer cells and examined the effects on sensitivity to compounds targeting aerobic glycolysis, a hallmark of cancer metabolism. Whereas the complete knockout of one ATG blocked autophagy and led to profound metabolic vulnerability, this was not the case for combinations of different nonhomozygous deletions. In cancer patients, the effect of ATG copy number loss was blunted at the protein level and did not lead to the accumulation of p62 as a sign of reduced autophagic flux. Thus, the autophagy pathway is shown to be markedly robust and resilient, even with the concomitant copy number loss of key autophagy genes.
Insights
Cancer cells with defects in autophagy genes (ATGs) may be vulnerable to metabolic drugs. However, even with copy number losses, the autophagy pathway remains robust, limiting therapeutic potential.
Area of Science:
- Cellular Biology
- Cancer Metabolism
- Molecular Oncology
Background:
- Autophagy is a cellular process that replenishes metabolites during energy stress, potentially sensitizing cancer cells to metabolic drugs.
- Defects in autophagy could indicate a metabolically vulnerable cancer state, creating a therapeutic window.
- While mutations in autophagy genes (ATGs) are rare, copy number losses frequently affect ATGs in various cancers.
Purpose of the Study:
- To investigate the impact of autophagy gene copy number loss on cancer cell sensitivity to drugs targeting aerobic glycolysis.
- To determine if reduced ATG copy numbers create a metabolic vulnerability in non-small cell lung cancer cells.
Main Methods:
- Utilized CRISPR/Cas9 technology to delete varying numbers of copies of key autophagy genes (MAP1LC3B/ATG8F, BECN1/ATG6, ATG10) in non-small cell lung cancer cells.
- Assessed the sensitivity of modified cancer cells to compounds targeting aerobic glycolysis.
- Analyzed protein levels and p62 accumulation in cancer patients with ATG copy number loss to evaluate autophagic flux.
Main Results:
- Complete knockout of a single ATG gene blocked autophagy and induced significant metabolic vulnerability.
- Combinations of different nonhomozygous ATG deletions did not result in a similar blockade or vulnerability.
- In cancer patients, ATG copy number loss had a blunted effect at the protein level, with no significant p62 accumulation indicating reduced autophagic flux.
Conclusions:
- The autophagy pathway exhibits remarkable robustness and resilience, even when key autophagy genes experience copy number loss.
- Concomitant copy number losses of multiple autophagy genes do not necessarily lead to a functionally impaired autophagy pathway or increased metabolic vulnerability in cancer.
- The resilience of autophagy suggests that targeting this pathway through copy number alterations alone may not be a universally effective anticancer strategy.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Genome Copying Errors
Cancers Originate from Somatic Mutations in a Single Cell
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

